Furthermore, a recent case report [107] describing the case of an elderly woman with primary myelofibrosis who consistently tested positive for COVID-19 evaluated the therapeutic improvement of combining ruxolitinib and PEGylated IFN treatment. The gene discussed is IFNA1; the disease is COVID-19.